Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Metamason Closes $3M Seed Round Led by 3P Equity Partners and Tsing Capital
  • USA - English


News provided by

Metamason

Jun 03, 2016, 13:40 ET

Share this article

Share toX

Share this article

Share toX

Respere™ by Metamason
Respere™ by Metamason
Youtube
Youtube

Los Angeles (PRWEB) June 03, 2016 -- Metamason Inc., a healthcare-focused 3D scanning and 3D printing company, today announced that it has closed a $3 million Series Seed financing round.

The raise was led by 3P Equity Partners, a manufacturing-focused private equity firm located in San Jose, CA; and Tsing Capital, known as China’s foremost cleantech venture capital firm. The round also included a collection of individual angel investors throughout the country.

Metamason empowers patients through curated personalization. It’s our goal to improve lives by transforming the CPAP experience.

Post this

Metamason founder and CEO Leslie Oliver Karpas said, “We are thrilled to reach this important milestone for the company. Our investors are confident that Metamason will be a disruptive, positive force in the $4 billion global sleep apnea market.”

According to COO/CFO and co-founder Cliff Sarkin, Metamason will use the seed investment to complete FDA regulatory clearance and run initial clinical trials for its patent-pending flagship product, Respere™—a custom fit, 3D-printed CPAP mask designed to revolutionize treatment for Obstructive Sleep Apnea, a chronic respiratory disorder affecting 1 in 4 men and 1 in 9 women in the US alone. The company also plans to execute a crowdfunding campaign later in 2016 and begin marketing activities in early 2017.

“We’re not just selling a product,” said Karpas. “We want to give patients and providers direct influence over the creation of objects that profoundly affect their lives.”

CPAP, he explained, is a good place to start. “Despite CPAP therapy's proven efficacy, over half of patients quit because of discomfort due to poor fit of their masks.”

Projected to become publicly available in Q2 2017, the Respere™ mask uses Metamason’s Scan·Fit·Print™ platform to incorporate digital scans of the patient’s face using a proprietary design algorithm, generating a CPAP mask that comfortably fits each patient’s unique facial topology. Each Respere™ product will be produced on demand, 3D-printed from soft medical grade silicone.

“Many people suffering from OSA can't remember the last time they had a good night’s sleep,” Karpas said. “Mass-produced masks fit poorly because every human face is different. Metamason empowers patients through curated personalization. It’s our goal to improve lives by transforming the CPAP experience.”

It has been a banner year for Metamason. In October 2015, Metamason won the startup pitch competition at Inside 3D Printing Santa Clara, and in March of this year, the company was chosen as one of five finalists for the SXSW Interactive 3DIY Innovation Award, garnering a flurry of positive press and being named one of “6 Cool Innovations That Are Making The World A Better Place” by reason.com.

Additionally, as a company that “leverage[s] exponential technologies to address humanity’s grand challenges,” Metamason was recently accepted into the prestigious Singularity University Startup Network. Now an SU Labs portfolio company, Metamason is poised to benefit from the resources and mentorship provided by the respected Silicon Valley think tank and research institution.

“We’re honored by the support of our investors and advisors—and galvanized by the outpouring of interest and enthusiasm from sleep doctors and patients,” said Sarkin, noting that the company has already begun expanding its team of designers and engineers, and is celebrating the opening of its new headquarters in downtown LA.

About Metamason:
Metamason’s healthcare-focused software platform uses 3D technology to create personalized, 3D-printed medical devices. The company’s proprietary Scan·Fit·Print™ process integrates 3D body scanning, patented algorithmic design and on-demand 3D printing to create ergonomic products that are individually customized for a perfect fit.

If you would like to know more about Metamason or seek information about employment and/or investment opportunities, please contact:

Charles Bohlen
Co-Founder & Director of Operations
811 West 7th Street, Suite 1138
Los Angeles, CA 90017
818-370-0731
charles(at)metamason(dot)com
http://www.metamason.com

Charles Bohlen, Metamason, http://www.metamason.com, +1 (818) 370-0731, [email protected]

Modal title

Respere™ by Metamason
Respere™ by Metamason
Respere™ Mask Fitting
Respere™ Mask Fitting
SCAN
SCAN
FIT
FIT
PRINT
PRINT
Respere™ by Metamason Respere™ Mask Fitting SCAN FIT PRINT

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.